News

Published on 24 May 2024 on Zacks via Yahoo Finance

Bicycle Therapeutics (BCYC) Up as PIPE Funding Set to Make $555M


Article preview image

Bicycle Therapeutics BCYC shares rallied 9.6% in the last trading session on May 23 after the company announced entering into a funding agreement with multiple institutional investors, new and existing, to issue and sell an aggregate of 25,933,706 American Depositary Shares (ADS) at $21.42 per share. Such impending transaction will be accomplished via a private investment in public equity (PIPE) financing.

Please note that one ADS of Bicycle Therapeutics represents one ordinary share of the company.

NASDAQ.BCYC price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Bicycle Therapeutics Lead Cancer Drug Combined With Merck's Blockbuster Drug...

On Thursday, Bicycle Therapeutics plc (NASDAQ:BCYC) announced that it presented data showing the...

Benzinga · via Yahoo Finance 13 Dec 2024

Is Bicycle Therapeutics plc (BCYC) Top Performing European Stock Heading into...

We recently published a list of 10 Top Performing European Stocks Heading into 2025. In this...

Insider Monkey · via Yahoo Finance 13 Nov 2024

Is Bicycle Therapeutics (BCYC) Stock Outpacing Its Medical Peers This Year?

The Medical group has plenty of great stocks, but investors should always be looking for companie...

Zacks · via Yahoo Finance 26 May 2024

Bicycle Therapeutics (BCYC) Up as PIPE Funding Set to Make $555M

Bicycle Therapeutics BCYC shares rallied 9.6% in the last trading session on May 23 after the com...

Zacks via Yahoo Finance 24 May 2024

Is Bicycle Therapeutics (BCYC) Outperforming Other Medical Stocks This Year?

The Medical group has plenty of great stocks, but investors should always be looking for companie...

Zacks via Yahoo Finance 21 May 2024

Upgrade: Analysts Just Made A Massive Increase To Their Bicycle Therapeutics plc (NASDAQ:BCYC)...

Bicycle Therapeutics plc (NASDAQ:BCYC) shareholders will have a reason to smile today, with the a...

Simply Wall St. via Yahoo Finance 7 May 2024

Bicycle Therapeutics (BCYC) Moves to Buy: Rationale Behind the Upgrade

Bicycle Therapeutics PLC Sponsored ADR (BCYC) could be a solid addition to your portfolio given i...

Zacks via Yahoo Finance 7 May 2024

Earnings Update: Bicycle Therapeutics plc (NASDAQ:BCYC) Just Reported Its Yearly Results And...

It's been a good week for Bicycle Therapeutics plc (NASDAQ:BCYC) shareholders, because the compan...

Simply Wall St. via Yahoo Finance 23 Feb 2024

Bicycle Therapeutics PLC CEO Kevin Lee Sells 8,703 Shares

On January 3, 2024, CEO Kevin Lee sold 8,703 shares of Bicycle Therapeutics PLC (NASDAQ:BCYC), ac...

GuruFocus.com via Yahoo Finance 5 Jan 2024

Bicycle Therapeutics plc (NASDAQ:BCYC) Analysts Just Trimmed Their Revenue Forecasts By 13%

One thing we could say about the analysts on Bicycle Therapeutics plc (NASDAQ:BCYC) - they aren't...

Simply Wall St. via Yahoo Finance 7 Nov 2023